Crossref
Impact of bone marrow angiogenesis, expression of osteopontin and vascular endothelial growth factor on myeloma patient response to the first line therapy
Medicina Fluminensis · 2016
DOI: 10.21860/52;3_390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina Fluminensis, 2016. Verfasst von Emina Babarović und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Babarović, E., Hadžisejdić, I., Štifter, S., Lučin, K., & Jonjić, N. (2016). Impact of bone marrow angiogenesis, expression of osteopontin and vascular endothelial growth factor on myeloma patient response to the first line therapy. Medicina Fluminensis. https://doi.org/10.21860/52;3_390
Vancouver
Babarović E, Hadžisejdić I, Štifter S, Lučin K, Jonjić N. Impact of bone marrow angiogenesis, expression of osteopontin and vascular endothelial growth factor on myeloma patient response to the first line therapy. Medicina Fluminensis. 2016. doi:10.21860/52;3_390
BibTeX
@article{Babarovi2016,
author = {Babarović, Emina and Hadžisejdić, Ita and Štifter, Sanja and Lučin, Ksenija and Jonjić, Nives},
title = {Impact of bone marrow angiogenesis, expression of osteopontin and vascular endothelial growth factor on myeloma patient response to the first line therapy},
journal = {Medicina Fluminensis},
year = {2016},
doi = {10.21860/52;3_390}
}
EUVIMED